AutoGenomics Pulls IPO

Vista-based AutoGenomics, a developer of molecular diagnostics hardware, has pulled its IPO, the firm said in a filing Wednesday evening. The firm said it has "elected not to pursue the sale of securities" but did not give a reason for the withdrawal. The firm had file for an IPo in July of 2008, looking to list on the NASDAQ as AGMX. AutoGenomics had previously raised funding from Palomar Ventures, although it's unclear how much of a stake the venture firm now holds in the compay. Palomar's Randy Lunn still sits on the company's board of directors.